Home / Adel (page 32)

Adel

Johnson & Johnson Posts Strong Q4 Results, Beats Estimates on Robust Cancer Drug Demand

Johnson & Johnson (NYSE:JNJ) reported fourth-quarter earnings and sales that exceeded analysts’ expectations, driven by strong demand for its cancer treatments and contributions from its recent acquisition of Shockwave Medical. Q4 Highlights Revenue: $22.52 billion, a 5.3% year-over-year increase. Adjusted EPS: $2.04 per share, down 11% YoY but above analysts’ …

Read More »

Oil Prices Dip as Markets React to Trump’s Energy Emergency Declaration and Tariff Speculation

Oil prices continued their decline on Wednesday, extending losses from the previous session. Markets are weighing the implications of U.S. President Donald Trump’s declaration of a national energy emergency and his proposed tariff policies. Market Performance Brent Crude Futures: Fell 36 cents (0.5%) to $78.93 per barrel as of 07:30 …

Read More »